8 gange den terapeutiske dosis) forårsagede midlertidig rødme, kløe og hypotension hos raske forsøgspersoner.
A dose of 3.2 mg/ kg intravenously (approximately 8 times the therapeutic dose) caused transient erythema, itching or hypotension in healthy subjects.